Tofacitinib and baricitinib are the first orally available, small-molecule inhibitors of Janus
kinase (JAK) enzymes to be approved for the treatment of RA. Tofacitinib is a selective JAK1 …

Historically, periodontal disease (gingivitis and periodontitis) has been recognized as being
primarily of bacterial origin. However, recent evidence indicates that while bacteria are …

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by progressive
polyarthritis that leads to cartilage and bone damage. Pre-clinical RA is a prolonged state …

Importance Knowing the future condition of a patient would enable a physician to customize
current therapeutic options to prevent disease worsening, but predicting that future condition …

Objective A systematic literature review (SLR; 2009–2014) to compare a target-oriented
approach with routine management in the treatment of rheumatoid arthritis (RA) to allow an …

Methotrexate (MTX) has been used for the treatment of rheumatoid arthritis (RA) for about
forty years and to date MTX remains the part of global standard of treatment for RA. The …

Objective To investigate the predictive value of baseline depression/anxiety on the
likelihood of achieving joint remission in rheumatoid arthritis (RA) and psoriatic arthritis …

Objective To evaluate rheumatoid arthritis (RA) disease activity and risk of RA‐associated
interstitial lung disease (RA‐ILD). Methods We investigated disease activity and risk of RA …

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by articular and
systemic manifestations, such as anemia, fatigue, osteoporosis, and increased risk for …

The biological DMARD (bDMARD) abatacept (Orencia®), a recombinant fusion protein,
selectively modulates a co-stimulatory signal necessary for T-cell activation. In the EU …